Cytotoxic evaluation of Melia azedarach in comparison with, Azadirachta indica and its phytochemical investigation
© Jafari et al.; licensee BioMed Central Ltd. 2013
Received: 7 February 2013
Accepted: 11 May 2013
Published: 16 May 2013
Melia azedarach L. is an important medicinal plant that is used for variety of ailments in Iranian traditional medicine. Azadirachta indica A. Juss is its allied species and possesses similar properties and effects. The present study was undertaken to investigate anticancer activity of these M. azedarach in comparison with A. indica on cancer cell lines and also to evaluate their safety in humans by testing them on normal cell line. The study also aimed to determine the active components that are responsible for medicinal effects of M. azedarach in traditional usages.
In this study, the cytotoxic activity of crude extracts from M. azedarach and A. indica leaves, pulps and seeds as well as three main fractions of their leaf extracts were assayed against HT-29, A-549, MCF-7 and HepG-2 and MDBK cell lines. MTT assay was used to evaluate their cytotoxic activities. Methanol leaf fraction of M. azedarach as the safest leaf fraction in terms of cytotoxicity was subjected for phytochemical study.
Results of the present study indicated that seed kernel extract of M. azedarach had the highest cytotoxic activity and selectivity to cancer cell lines (IC50 range of 8.18- 60.10 Î¼g mL-1). In contrast to crude seed extract of A. indica, crude pulp and crude leaf extracts of this plant showed remarkably stronger anti-prolifrative activity (IC50 ranges of 83.45 - 212.16 Î¼g mL-1 and 34.11- 95.51 Î¼g mL-1 respectively) than those of M. azedarach (all IC50 values of both plants > 650 Î¼g mL-1). The phytochemical analysis led to the isolation of four flavonol 3-O-glycosides including rutin, kaempferol-3-O-robinobioside, kaempferol-3-O-rutinoside and isoquercetin along with a purin nucleoside, Î²-adenosine.
The anti-prolifrative potentials of extracts from different parts of M. azedarach and A. indica were determined. By comparison, methanol leaf fraction of M. azedarach seems to be safer in terms of cytotoxicity. Our study shows that flavonols are abundant in the leaves of M. azedarach and these compounds seem to be responsible for many of medicinal effects exploited in the traditional uses.
Traditional uses of M. azedarach
Temperament normalizer in elderly people and people how suffer from cold dystemperament; headache and other head pains reliever (through inhalation of its sent) ;
Anthelmintic; remedy for kidney stones; treatment of leprosy and vitiligo ;
Treatment of leprosy and vitiligo; remedy for tinea and head wounds; hair growth inducer ;
Phlegmatic fevers and coughs reliever .
In Iranian traditional medicine, just whole plants or mixtures of them are used and there is a belief that pure compounds even plant-derived ones have no natural properties like whole plants . Therefore, cytotoxic evaluation of crude extracts can gives us better insight into cytotoxic effects of whole plants. In all studied traditional literatures except one , fruits of M. azedarach have been mentioned as the plant toxic and fatal part [2, 10–12]. It has been stated that they are harmful to the stomach and chest muscles [10, 11]. Recent studies also support toxicity of the fruit . Tetranortriterpenes known as meliatoxins have been reported as toxic principles of the fruit . In contrast to the limitation in fruit consumption, leaves of the plant have been prescribed for a variety of indications. Therefore, in order to detailed investigation of the leaves, their main fractions were also studied and the methanol leaf fraction of M. azedarach was selected for isolation of active compounds.
In the present study, crude extract of leaves, pulps and seeds of M. azedarach and A. indica as well as different fractions of their leaves were studied against four cancer cell lines (HT29, A549, MCF7 and HepG2) and one normal cell line (MDBK). It is noteworthy that our study is the first report about cytotoxic activity of M. azedarach seeds.
General experimental procedures
UV spectra were recorded on an Optizen 2120UV plus UV/VIS spectrophotometer. NMR was run on a Bruker DRX-500 spectrometer (1H, 500 MHz; 13C, 125 MHz). Semi-preparative HPLC was carried out with a KNAUERHPLC system (Germany) and Eurospher 100â€“7 RP C18 (250 Ã— 20 mm; Macherey Nagel) column. Silica gel (35â€“70, 70â€“230 and 230â€“400 mesh, Merck) and Sephadex LH20 (Fluka BioChemika, 25â€“100 Î¼m) were used for column chromatography. TLC analysis was performed on Silica gel 60 F254 or Silica gel 60 RP-18 F254S; Merck plates (10 Ã— 10 cm).
Leaves and fruits of M. azedarach and A. indica were collected from Gorgan (Golestan Province) and Bandar Abbas (Hormozgan Province) respectively. Then, their voucher specimens were deposited at the Herbarium of Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran (Voucher No. of M. azedarach: 6710 THE; Voucher No. of A. indica: 6640 THE).
Collected leaves and fruits were separately dried in shade, at room temperature. The dried fruits were de-husked and decorticated and their seed kernels were separated from their husks and pulps. The leaves, pulps of fruits (together with their husks), and seed kernels of each plant were separately crushed into fine powders.
Preparation of extracts for cytotoxic assay
Percolation technique by methanol/water (80:20, v/v) at room temperature was used for total extraction of the leaves, pulps and seed kernels of two species. The extraction procedure included three consecutive extractions of 48 hours, using fresh solvent each time. The solvent was evaporated under reduced pressure to dry. Both dried leaf extracts fractionated with n-hexane (in order to remove the fatty materials and chlorophylls), chloroform, ethyl acetate and methanol successively. After evaporating solvents, fractions were completely dried to remove their trace solvents. To prepare different concentrations of each extract (650 or 1000 Î¼g/mL) for cytotoxic assay, DMSO 10% was used.
Extraction and isolation
The powdered leaves (1.20 kg) of Melia azedarach were extracted three times (every 48 hours) with 80% methanol at room temperature. The solvent was evaporated at reduced pressure to yield 332.4 g of a crude extract. This extract was fractionated on silica gel (35â€“70 mesh) using four solvents - hexane, chloroform, ethyl acetate and methanol- successively. The solvent in each extract was completely evaporated under reduced pressure to yield 28.9 g (8.70%), 56.5 g (16.99%), 14.3 g (4.31%), and 220.0 g (66.18%), respectively. Then, to isolate the pure compounds, methanol fraction was subjected to chromatography on a silica gel column (70â€“230 mesh; 10Ã—15 cm) eluted with gradient of AcOEt/MeOH (100% AcOEt to 100% MeOH). The chromatographic process was monitored by TLC. TLC sheets were developed using BAW system (n-BuOH/HOAc/H2O, 3:3:1), viewed under UV light and then sprayed with anisaldehyde-sulphuric acid reagent. Similar fractions were pooled together to give five fractions (M1-M5). Fractions M3 (28.7 g), collected with AcOEt/MeOH (5:5), was chromatographed again on a silica gel column (230â€“400 mesh; 5Ã—15 cm) with a gradient of AcOEt/MeOH (9:1 to 1:9) to give three fractions (M3a- M3d). Spraying with anisaldehyde-sulphuric acid reagent revealed a group of yellow spots on the TLC plate of M3b.
This fraction was repeatedly chromatographed over Sephadex LH 20 (eluted with MeOH) and monitored by TLC until separation of yellow spots from non-target compounds (e.g. polysaccharides). Finally, three fractions were obtained: M3b1- M3b3.
Rf values Ã—100: 52 (system: BAW (n-BuOH: HOAc: H2O, 3:3:1)); ninhydrin and dragendrof-positive compound; 1H-NMR (DMSO-d6): Î´ 8.34 (1H, s, H-8), 8.12 (1H, s, H-2), 7.34 (2H, bs, NH2) 5.85 (1H, d, J = 6 Hz, H-1'Î±), 5.46 (2H, bs, OH-2', OH-5'), 5.25 (2H, bs, OH-3'), 4.59 (1H, bs, H-2'), 4.12 (1H, bs, H-3'), 3.94 (1H, d, J = 3, H-4'), 3.66 (1H, bs, H-5'a), 3.52 (1H, bs, H-5'b). 13C NMR (DMSO-d6): Î´ 156.23 (C-6), 152.49 (C-2), 149.11 (C-4), 140.03 (C-8), 119.41 (C-5), 87.98 (C-1'), 85.99 (C-4'), 73.53 (C-2'), 70.74 (C-3'), 61.75 (C-5').
Amorphous yellow powder, Rf values Ã—100: 57 (system: BAW (n-BuOH: HOAc: H2O, 3:3:1); 1H-NMR (DMSO-d6): Î´ 12.52 (1H, s, OH-5), 7.55 (2H, d, J = 8 Hz, H-2' and H-6'), 6.85 (1H, d, J = 8 Hz, H-5'), 6.39 (1H, J = 2 Hz, H-8), 6.20 (1H, J = 2 Hz, H-6), 5.34 (1 H, d, J = 7 Hz, H-1'' anomeric proton of glucosyl), 4.40 (1H, bs, H-1''' anomeric proton of rhamnosyl), 3.06-3.72 (m, remaining sugar protons) and 0.99 (3H, d, J = 6 Hz, CH3 rhamnosyl). 13C NMR (DMSO-d6): Î´ 177.36 (C-4); 164.45 (C-7); 161,25 (C-5); 156.65 (C-9); 156.47 (C-2); 148.50 (C-4'), 144.81 (C-3'); 133.30 (C-3); 121.64 (C-6'); 121.18 (C-1'); 116.27 (C-5'); 115.27 (C-2'); 103.88 (C-10); 101.24 (C-1''); 100.80 (C-1'''); 98.82 (C-6); 93.69 (C-8); 76.46 (C-3''); 75.92 (C-5''); 74.11 (C-2''); 71.87 (C-4'''), 70.59 (C-2'''), 70.41 (C-3'''), 70.02 (C-4''); 68.31 (C-5'''), 67.04 (C-6''); and 17.80 (C-6''').
Amorphous yellow powder, Rf values Ã—100: 60 (system: BAW (n-BuOH: HOAc: H2O, 3:3:1)); 1H-NMR (DMSO-d6): Î´ 12.52 (1H, s, OH-5), 8.04 (2H, d, J= 8 Hz, H-2' and H-6'), 6.86 (2H, d, J= 8 Hz, H-3' and H-5'), 6.34 (1H, bs, H-8), 6.13 (1H, bs, H-6), 5.28 (1H, d, J= 7.7 Hz, H-1'' anomeric proton of galactosyl), 4.40 (1H, bs, H-1''' anomeric proton of rhamnosyl), 3.08 - 3.61 (m, remaining sugar protons) and 1.07 (3H, d, J= 6 Hz, CH3 rhamnosyl).13C NMR (DMSO-d6): Î´ 177.10 (C-4); 164.4 (C-7); 161.10 (C-5); 160.00 (C-4'), 156.64 (C-9); 156.23 (C-2); 133.23 (C-3); 130.90 (C-2', C-6'); 120.87 (C-1'); 115.08 (C-3', C-5'); 103.4 (C-10); 102.31 (C-1''); 100.07 (C-1'''); 98.8 (C-6); 94.06 (C-8); 73.49 (C-5''); 73.03 (C-3''); 71.92 (C-4'''), 71.12 (C-2''), 70.42, 70.62 (C-2''',C-3'''), 68.29 (C-5'''), 68.01 (4''); 65.32 (C-6''); and 17.92 (C-6''').
Yellow crystals, Rf values Ã—100: 65 (system: BAW (n-BuOH: HOAc: H2O, 3:3:1));1H-NMR (DMSO-d6): Î´ 12.54 (1H, s, OH-5), 7.98 (2H, d, J = 9 Hz, H-2' and H-6'), 6.88 (2H, d, J = 9 Hz, H-3' and H-5'), 6.38 (1H, bs, H-8), 6.18 (1H, bs, H-6), 5.30 (1H, d, J= 7.5 Hz, H-1'' anomeric proton of glucosyl), 4.38 (1H, bs, H-1''' anomeric proton of rhamnosyl), 3.04 - 3.86 (m, remaining sugar protons) and 0.98 (3H, d, J = 6 Hz, CH3 rhamnosyl). 13C NMR (DMSO-d6): Î´ 177.29 (C-4); 165.28 (C-7); 161.21 (C-5); 160.00 (C-4'), 156.78 (C-9); 156.66 (C-2); 133.22 (C-3); 130.94 (C-2', C-6'); 120.94 (C-1'); 115.18 (C-3', C-5'); 103.67 (C-10); 101.50 (C-1''); 100.85 (C-1'''); 99.10 (C-6); 93.98 (C-8); 76.41 (C-3''); 75.76 (C-5''); 74.24 (2''), 71.87 (C-4'''), 70.65 (C-3'''), 70.41 (C-2'''), 69.96 (C-4''), 68.33 (C-5'''); 66.97 (6''); and 17.82 (C-6''').
Amorphous yellow powder, Rf values Ã—100: 70 (system: BAW (n-BuOH: HOAc: H2O, 3:3:1)); 1H-NMR (DMSO-d6): Î´ 12.6 (1H, s, OH-5), 7.58 (2H, d, J= 9 Hz, H-2' and H-6'), 6.84 (2H, d, J= 9 Hz, H-5'), 6.40 (1H, d, J= 2 Hz, H-8), 6.19 (1H, d, J= 2 Hz, H-6), 5.43 (1H, d, J= 7 Hz, H-1'' anomeric proton of glucosyl), 3.09 - 3.70 (m, remaining sugar protons). 13C NMR (DMSO-d6): Î´ 177.56 (C-4); 164.45 (C-7); 161.33 (C-5); 156.49, 156.35 (C-2, C-9); 148.64 (C-4'); 144.97 (C-3'); 133. 45 (C-3); 121.78 (C-6'); 121.25 (C-1'); 116.29 (C-5'); 115.36 (C-2'); 104.05 (C-10); 101.02 (C-1''); 98.89 (C-6); 93.73 (C-8); 77.65 (C-5''); 76.56 (C-3''); 74.19 (C-2''); 70.01 (C-4''); 61.05 (C-6'').
Determination of total flavonoid content
The total content of flavonoids was determined using the spectrophotometric method described by Tomczyk et al.. The results were expressed as mg of quercetin equivalents (QE) per 100 mg of fraction.
Four tumor cell lines, HT-29 (human colon adenocarcinoma), A-549 (non-small cell line carcinoma), HepG-2 (hepatocellular carcinoma) and MCF-7 (human breast adenocarcinoma) and one normal cell line, MDBK (bovine kidney cells) were obtained from Pasture Institute of Iran, Tehran, Iran.
All cell lines were grown in suitable media supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin and maintained at 37Â°C in a 5% CO2 incubator.
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric assay is used to assess cell viability in the presence of different extracts . Cells were seeded into 96-well plates and incubated for 24 h at 37Â°C. Then the medium was replaced with fresh medium containing different concentrations of test extracts. After 72 h incubation at 37Â°C, the medium was changed by fresh medium containing MTT and incubated for additional 4 h. Thereafter, MTT was removed and remaining formazan crystals were completely dissolved in DMSO. Afterwards, the absorbance was recorded at 570 nm, using an ELISA reader. The inhibitory rate was calculated by the following formula:
Relative viability (%) = (Absorbance test/Absorbance control) Ã—100. IC50 value was defined as the concentration of the extract to produce a 50% reduction in viability of cells relative to the negative control (wells exposed to the solvent without any extract). All experiments were performed in triplicate. Tamoxifen was used as positive control.
Results and discussion
Anticancer activity of M. azedarach and A. indica extracts and fractions on different cell lines
C. Seed E.
C. Pulp E.
C. Leaf E.
Ethyl acetate F.
The results in Table 2 also indicated that crude pulp and crude leaf extracts of A. indica, in contrast to its seed extract, showed remarkably stronger anti-prolifrative activity than those of M. azedarach. Moreover, in comparison with Persian lilac, most of neem samples exhibited relatively lower IC50 on normal cell line, which indicated that neem is more harmful than Persian lilac and its prescription in high doses need more caution.
It is also noticeable that methanol leaf fractions of both species were inactive against studied cancer cell lines at concentrations blow 1000 Î¼g mL-1 and their toxicities on normal line especially that of Persian lilac were less than other leaf fractions. Based on these results as well as the yields of fractions, Persian lilac methanol fraction was selected for active compound isolation. Another point is that traditional herbal medicines are generally prepared as infusions, decoctions, bath formulations and so on in which polar compounds are mostly extracted and lead to pharmacological effects. The methanol fraction as most polar fraction of the leaves is expected to contain foresaid active components more than others.
As mentioned, most of previous phytochemical and pharmacological investigations have focused on limonoids and other triterpenoids as active components of M. azedarach. Nevertheless, phenolic compounds in particular flavonol glycosides are present in this plant in high levels and it seems that they are significantly involved in the medicinal effects of this plant. Analysis of total flavonoid content in methanol leaf fractions of Persian lilac and neem showed that they both contained high levels of flavonols (72.6 mg QE/100 mg of fraction and 77.8 mg QE/100 mg of fraction respectively). Taking look at the previous reports on medicinal effects of the isolated flavonols shows that they can be responsible for many effects which are listed in Table 1. For instance, flavonols as quercetin, kaempferol and their glycosides can be used as antidote for a broad range of toxic materials as snake venoms [22, 23], heavy metals, T2 toxin , bacterial toxins (e.g. Microcystin, botulinum neurotoxin) [25, 26], mustard , bisphenol A , arsenic . In addition, rutin and quercetin were reported to ameliorate inflammatory bowel disease . This effect may be associated with the traditional prescription of Persian lilac for chronic intestinal obstructions. Also, rutin and quercetin are able to enhance wound healing [31, 32] so that they are effective in treatment of suppurative wounds . Rutin has showed anthelmintic activity against human lymphatic filariasis  and Haemonchus contortus. Moreover, 3-O-glycosides of kaempferol and quercetin exhibited diuretic activity  which was found to be mediated by the action at A1 adenosine receptors like caffeine and theophylline . This activity can be a helpful factor in kidney stone treatment too . As a remedy for vitiligo, quercetin has potential to enhance melanogenesis on human epidermis by affecting on maturation of melanosomes  and increase the activity and biosynthesis of tyrosinase in melanoma cells and in human melanocytes . Regarding to hair growth, this compound was reported to treat and prevent of alopecia areata  and inhibit of 5 Î±-reductase .
Our study determined the anti-prolifrative potentials of extracts from different parts of M. azedarach and A. indica. Some extracts such as seeds extract of M. azedarach are strongly and selectively able to induce cell death of studied cell lines. Methanol leaf fractions were found to be safer in terms of cytotoxicity and abundant in flavonols. Although these plants are famous for their limonoids, it seems flavonols can be in charge for many medicinal effects of leaves of the plants. The present study therefore can provide new context for further researches.
It should be noted that in the present study, cytotoxic assay by means of cell culture as an In vitro model cannot assuredly confirm safety or toxicity of the extracts . Although the mentioned plants have been used as traditional medicines for centuries, they are abundant in cytotoxic, insecticide and pesticide compounds. So, performing further in vivo animal and human assays is suggested to confirm the safeties of these plants in different aspects.
The authors wish to thank Traditional Medicine and Materia Medica Research Center, Shahid Beheshti University of Medical Sciences for providing the facilities for the study. This research has been supported by Tehran University of Medical Sciences and Health Services (Grant No. 16977-33-01-91).
- Puri HS: Neem: The Divine Tree Azadirachta indica. 1999, Australia: Harwood Academic PublishersView ArticleGoogle Scholar
- Aghili Alavi Khorasani MH:Makhzan al-Advieh. Edited by: Shams Ardakani MR, Rahimi R, Farjadmand F. 2009, Tehran: Sabz-arang and Tehran University of Medical Sciences,Google Scholar
- Zargari A: Medicinal Plants. 1990, Tehran: Tehran University Press, 1:Google Scholar
- Carpinella MC, DefagÃ³ MT, Valladares G, Palacios SM: Role of Melia azedarach L. (Meliaceae) for the control of insects and acari: present status and future prospects. Advances in Phytomedicine Series: Naturally Occurring Bioactive Compounds. Edited by: Rai M, Carpinella MC. 2006, Amsterdam: Elsevier, Volume 3: 81-View ArticleGoogle Scholar
- Koul O, Seema W: Neem: Today and in The New Millennium. 2004, New York: Kluwer Academic PublishersView ArticleGoogle Scholar
- Rishi K, Ram S, Suhag MP, Kalidhar SB: Chemical components and insecticidal properties of bakain (Melia azedarach L.) - a review. Agric Rev. 2003, 24 (2): 101-115.Google Scholar
- Trudel RE, Bomblies A: Larvicidal effects of chinaberry (Melia azederach) powder on Anopheles arabiensis in Ethiopia. Parasit Vector. 2011, 4: 72. 10.1186/1756-3305-4-72.View ArticleGoogle Scholar
- Dousti M, Ram MH: Evidence-based traditional persian medicine. Evidence-Based Practice in Complementary and Alternative Medicine. Edited by: Chiappelli F, Ramchandani MH, Singh RH, Rastogi S. 2012, Berlin, Heidelberg: Springer-Verlag, 79-96.View ArticleGoogle Scholar
- Ansarishirazi A:Ekhtiarat Badiee. Edited by: Mir MT. 1993, Tehran: The drug distributing company of Razi,Google Scholar
- Avicenna: Al-Qanoon Fit-Tib (Canon in Medicine), book 2. Translated by Sharafkandi A. 1991, Tehran: Soroush PressGoogle Scholar
- Jorjani SE: Zakhireh-ye Kharazmshahi (The oldest Persian comprehensive book of medicine). Volume 3. Edited by: Mohhareri MR. 2002, Tehran: Academy of Medical Sciences of I.R. IranGoogle Scholar
- Tonekaboni MM: Tohfatul Momineen. Edited by: Shams Ardakani MR, Rahimi R, Farjadmand F. 2008, Tehran: Nashre shahrGoogle Scholar
- Knight AP: A Guide to Poisonous House and Garden Plants. 2007, USA: Teton New MediaView ArticleGoogle Scholar
- Oelrichs PB, Hill MW, Vallely PJ, Macleod JK, Molinski TF: Toxic tetranortriterpenes of the fruit of melia azedarach. Phyrochemistry. 1983, 22 (2): 531-534. 10.1016/0031-9422(83)83039-8.View ArticleGoogle Scholar
- Tomczyk M, PleszczyÅ„ska M, Wiater A: Variation in total polyphenolics contents of aerial parts of Potentilla species and their anticariogenic activity. Molecules. 2010, 15: 4639-4651. 10.3390/molecules15074639.View ArticlePubMedGoogle Scholar
- Alley MC, Scudiero DA, Monkes A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR: Feasibility of drug screening with panel of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48: 589-601.PubMedGoogle Scholar
- Liu H-B, Zhang C-R, Dong S-H, Dong L, Wu Y, Yue J-M: Limonoids and triterpenoids from the seeds of Melia azedarach. Chem Pharm Bull. 2011, 59: 1003-1007. 10.1248/cpb.59.1003.View ArticlePubMedGoogle Scholar
- Kelecom A, Cabral MMO, Garcia ES: A new euphane triterpene from the Brazilian Melia azedarach. J Braz Chem Soc. 1996, 7 (1): 39-41. 10.5935/0103-5053.19960006.View ArticleGoogle Scholar
- Cabral MMO, Garcia ES, Kelecom A: Lignanes from the Brazilian Melia azedarach and their activity in Rhodnius prolixus (Hemiptera, Reduviidae). Mem Inst Oswaldo Cruz. 1995, 90 (6): 759-763.View ArticlePubMedGoogle Scholar
- Agrawal PK: Carbon-13 NMR of Flavonoids. 1989, New York: ElsevierGoogle Scholar
- Ciuffreda P, Casati S, Manzocchi A: Spectral assignments and reference data: Complete 1H and 13C NMR spectral assignment of Î±- and Î²-adenosine, 2'-deoxyadenosine and their acetate derivatives. Magn Reson Chem. 2007, 45: 781-784. 10.1002/mrc.2036.View ArticlePubMedGoogle Scholar
- Mors WB, Nascimento MC, Ruppelt Pereira BM, Pereira NB: Plant natural products active against snake bite - the molecular approach. Phytochemistry. 2000, 55 (6): 627-642. 10.1016/S0031-9422(00)00229-6.View ArticlePubMedGoogle Scholar
- Cintra-Francischinelli M, Silva MG, Andréo-Filho N, Gerenutti M, Cintra ACO, Giglio JR, Leite GB, Cruz-Höfling MA, Rodrigues-Simioni L, Oshima-Franco Y: Antibothropic action of Casearia sylvestris Sw. (Flacourtiaceae) extracts. Phytother Res. 2008, 22 (6): 784-790. 10.1002/ptr.2365.View ArticlePubMedGoogle Scholar
- El-Sawia NM, Al-Seenia MN: Assessment of flavonoids as rutin for detoxification of T-2 Toxin. J Appl Anim Res. 2009, 35 (1): 57-60. 10.1080/09712119.2009.9706985.View ArticleGoogle Scholar
- Jayaraj R, Deb U, Bhaskar ASB, Prasad GBKS, Lakshmana Rao PV: Hepatoprotective efficacy of certain flavonoids against microcystin induced toxicity in mice. Environ Toxicol. 2007, 22 (2): 472-479.View ArticlePubMedGoogle Scholar
- Sakane I, Sawamura S-I, Ohno T, Nishimura M, Umehara K: Isolation and determination of antidotes for botulinum neurotoxin from black tea extract. Nihon Yakurigaku Zasshi. 2002, 120 (1): 116P-118P.PubMedGoogle Scholar
- Vijayaraghavan R, Gautam A: Flavonoid treatment for mustard agents' toxicity. Oxidative Stress – Environmental Induction and Dietary Antioxidants. Edited by: Lushchak V. 2012, Croatia: InTech, 249-262.Google Scholar
- Verma RJ, Sangai NP: The ameliorative effect of black tea extract and quercetin on bisphenol A-induced cytotoxicity. Acta Pol Pharm. 2009, 66 (1): 41-44.PubMedGoogle Scholar
- Ghosh A, Mandal AK, Sarkar S, Panda S, Das N: Nanoencapsulation of quercetin enhances its dietary efficacy in combating arsenic-induced oxidative damage in liver and brain of rats. Life Sci. 2009, 84: 75-80. 10.1016/j.lfs.2008.11.001.View ArticlePubMedGoogle Scholar
- Kim H, Kong H, Choi B, Yang Y, Kim Y, Lim MJ, Neckers L, Jung Y: Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharmaceut Res. 2005, 22 (9): 1499-1509. 10.1007/s11095-005-6250-z.View ArticleGoogle Scholar
- Akkol EK, Acɪkara OB, SÃ¼ntar I, Citoğlu GS, Keleş H, Ergene B: Enhancement of wound healing by topical application of Scorzonera species: Determination of the constituents by HPLC with new validated reverse phase method. J Ethnopharmacol. 2011, 137: 1018-1027. 10.1016/j.jep.2011.07.029.View ArticleGoogle Scholar
- Gomathi K, Gopinath D, Rafiuddin Ahmed M, Jayakumar R: Quercetin incorporated collagen matrices for dermal wound healing processes in rat. Biomaterials. 2003, 24: 2767-2772. 10.1016/S0142-9612(03)00059-0.View ArticlePubMedGoogle Scholar
- Timofeev AA, Maksiutina NP, Voĭtenko GN, Dobrovol'skiĭ IN: The use of quercetin granules for treating suppurative soft-tissue wounds of the maxillofacial area and neck. Stomatologiia (Mosk). 1989, 68 (6): 11-13.Google Scholar
- Lakshmi V, Joseph SK, Srivastava S, Verma SK, Sahoo MK, Dube V, Mishra SK, Murthy PK: Antifilarial activity in vitro and in vivo of some flavonoids tested against Brugia malayi. Acta Trop. 2010, 116: 127-133. 10.1016/j.actatropica.2010.06.006.View ArticlePubMedGoogle Scholar
- Barrau E, Fabre N, Fouraste I, Hoste H: Effect of bioactive compounds from Sainfoin (Onobrychis viciifolia Scop.) on the in vitro larval migration of Haemonchus contortus: role of tannins and flavonol glycosides. Parasitology. 2005, 131: 531-538. 10.1017/S0031182005008024.View ArticlePubMedGoogle Scholar
- Brantner AH, Males Z: Quality assessment of Paliurus spina-christi extracts. J Ethnopharmacol. 1999, 66: 175-179. 10.1016/S0378-8741(98)00180-9.View ArticlePubMedGoogle Scholar
- Alexander SPH: Flavonoids as antagonists at a1 adenosine receptors. Phytother Res. 2006, 20: 1009-1012. 10.1002/ptr.1975.View ArticlePubMedGoogle Scholar
- Yuliana ND, Khatib A, Link-Struensee AMR, Ijzerman AP, Rungkat-Zakaria F, Choi YH, Verpoorte R: Adenosine A1 receptor binding activity of methoxy flavonoids from Orthosiphon stamineus. Planta Med. 2009, 75: 132-136. 10.1055/s-0028-1088379.View ArticlePubMedGoogle Scholar
- Takeyama R, Takekoshi S, Nagata H, Yoshiyuki Osamura R, Kawana S: Quercetin-induced melanogenesis in a reconstituted three-dimensional human epidermal model. J Mol Histol. 2004, 35: 157-165.View ArticlePubMedGoogle Scholar
- Nagata H, Takekoshi S, Takeyama R, Homma T, Yoshiyuki Osamura R: Quercetin enhances melanogenesis by increasing the activity and synthesis of tyrosinase in human melanoma cells and in normal human melanocytes. Pigm Cell Res. 2004, 17: 66-73. 10.1046/j.1600-0749.2003.00113.x.View ArticleGoogle Scholar
- Wikramanayake TC, Villasante AC, Mauro LM, Perez CI, Schachner LA, Jimenez JJ: Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model. Cell Stress Chaperones. 2012, 17: 267-274. 10.1007/s12192-011-0305-3.PubMed CentralView ArticlePubMedGoogle Scholar
- Hiipakka RA, Zhang H-Z, Dai W, Dai Q, Liao S: Structure–activity relationships for inhibition of human 5α-reductases by polyphenols. Biochem Pharmacol. 2002, 63: 1165-1176. 10.1016/S0006-2952(02)00848-1.View ArticlePubMedGoogle Scholar
- Shetab-Boushehri SV, Abdollahi M: Current concerns on the validity of in vitro models that use transformed neoplastic cells in pharmacology and toxicology. Int J Pharmacol. 2012, 8: 594-595. 10.3923/ijp.2012.594.595.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.